AETHLON MEDICAL INC has raised $2.2M in total funding.
AETHLON MEDICAL INC is headquartered in San Diego, CA.
There are unmet needs in treating cancer and life-threatening viral infections, including patients unresponsive or intolerant to standard-of-care therapy.
Aethlon is developing the Hemopurifier, a clinical-stage therapeutic device that selectively removes circulating pathogenic targets from biologic fluids to improve patient outcomes.
The Hemopurifier holds U.S. FDA Breakthrough Device designations in both oncology and infectious disease.
Aethlon Medical is a publicly traded company on Nasdaq under the ticker AEMD.
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.